Combination between 4-{3-[cis-hexahydrocyclopenta[c]pyrrol-2(1H)-yl]propoxy}-benzamide of formula (I): or an addition salt thereof with a pharmaceutically acceptable acid or base, and an NMDA glutamatergic receptor antagonist.本發明係關於式(I)之4-{3-[順式-六氫環戊并[c]吡咯-2(1H)-基]丙氧基}苯甲醯胺:(或其與醫藥上可接受之酸或鹼之加成鹽)與NMDA麩胺酸激導性受體拮抗劑之結合。